Xbrane Biopharma AB Market Cap

Xbrane Biopharma AB has a market cap or net worth of 121.55 million as of March 9, 2026. Its market cap has decreased by -50.11% in one year.

Market Cap

121.55M

Enterprise Value

93.27M

Revenue

152.35M

Ranking

n/a

PE Ratio

0.96

Stock Price

5.90

Market Cap Chart

Since February 3, 2016, Xbrane Biopharma AB's market cap has decreased from 131.05M to 121.55M, a decrease of -7.25%. That is a compound annual growth rate of -0.74%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	123.41M	-41.28%
Dec 30, 2025	210.17M	-14.54%
Dec 30, 2024	245.94M	-17.28%
Dec 29, 2023	297.31M	-86.83%
Dec 30, 2022	2.26B	-13.94%
Dec 30, 2021	2.62B	58.03%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Active Biotech AB	115.46M
IRLAB Therapeutics AB	135.90M
Alligator Bioscience AB	104.66M
NextCell Pharma AB	147.71M
Annexin Pharmaceuticals AB	102.36M
Simris Group AB (PUBL)	157.93M
Magle Chemoswed Holding AB	161.07M
Biosergen AB	89.23M

Market Cap Rankings